αααααβααΎαIMCR β’ NASDAQ
add
Immunocore Holdings PLC - ADR
31.09$
30 αα·αα»ααΆ, 1:23:32 PM ααααβααα -4 · USD · NASDAQ · ααα
ααααΈαααααΆααα·αααα½ααα»αααααΌα
αα·αααΈαα»α
31.12$
α
αααααααααααα
30.76$ - 31.78$
α
ααααααα½αααααΆαα
α»αααααα
23.15$ - 41.53$
ααΎαβαα»αβααΈααααΆα
1.56Β αααΈααΆα USD
ααα ααα½αααΌαααααα
510.36Β ααΆαα
ααΆααααααΌαα
αααα
NASDAQ
ααααααΆαααΈααααΆα
α α·ααααααααα»
αααΆαααΆαααααααΆααα
αααΌα
α
αααΌα
α
αααΌααα»ααα
| (USD) | ααΈααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌα | 93.88Β ααΆα | 33.16% |
α
αααΆαααααα·ααααα·ααΆα | 96.67Β ααΆα | -0.08% |
α
αααΌααα»ααα | 5.02Β ααΆα | 120.56% |
ααααΆααα
αααααα»ααα | 5.35 | 115.44% |
βα
αααΌααα»αααβαααα»ααα½αααΆαα αα»α | 0.10 | 116.34% |
α
αααΌααα»ααααα»αααΆαααααΆαα αααα ααΆαααααα αα·αααΆαααΆααααααα | -2.76Β ααΆα | 89.16% |
α’ααααΆαααααααααΆαααααα·αααααΆα | 17.44% | β |
αααααΈαααα»ααα
ααααααααα»α
ααΆαααα½ααα»αααααΌαααα»α
| (USD) | ααΈααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
ααΆα
αααααΆαα αα·αααΆααα·αα·αααααααααααααΈ | 837.03Β ααΆα | 0.51% |
ααααααααα»α | 1.03Β αααΈααΆα | 3.42% |
ααΆαααα½ααα»αααααΌαααα»α | 649.53Β ααΆα | 2.38% |
ααΌαβααααα»α | 378.48Β ααΆα | β |
ααΆαα αα»αβαα·αβααΆααααΆαααα | 50.23Β ααΆα | β |
ααααααααααΉαααααα
| 4.13 | β |
ααα
ααααααΎαααααα | -0.89% | β |
ααα
ααααααΎααΎααα»α | -1.13% | β |
ααα αΌαβααΆα
αβααααΆααβ
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα
| (USD) | ααΈααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌααα»ααα | 5.02Β ααΆα | 120.56% |
ααΆα
αααααΆααααΈααααα·ααααα·ααΆα | 435.00Β ααΆαα | 109.48% |
ααΆα
αααααΆααααΈααΆααα·αα·ααα | 9.70Β ααΆα | 2,356.28% |
ααΆα
αααααΆααααΈα α·ααααβαααααΆα | 2.55Β ααΆα | -99.36% |
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα | 21.11Β ααΆα | -94.59% |
ααα αΌαααΆα
αααααΆααααααα | -59.40Β ααΆα | -16,674.99% |
α’αααΈ
Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology. Wikipedia
ααΆααααααΎαα‘αΎα
2008
αααααβαααααΆα
αα»ααααα·α
493
